PAMP
TGTX icon

Polar Asset Management Partners’s TG Therapeutics TGTX Stock Holding History

Polar Asset Management Partners’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,200
Closed -$505K – 827
2024
Q1 		$505K Sell
33,200
-235,800
-88% -$3.76M 0.01% 466
2023
Q4 		$4.59M Buy
+269,000
New +$3.13M 0.08% 233

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Polar Asset Management Partners's TGTX Position: Q2 2024 in Review

Polar Asset Management Partners sold out of TG Therapeutics (TGTX) in Q2 2024, closing a stake of 33,200 shares — an estimated $505K sold.

Polar Asset Management Partners first reported a position in TGTX in Q4 2023 and held it in 2 quarters. The position peaked at $4.59M in Q4 2023. 259 funds tracked by Wall St. Rank hold TGTX as of Q2 2024.

  • Polar Asset Management Partners reported no remaining TG Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Polar Asset Management Partners sold 33,200 TG Therapeutics shares in Q2 2024, an estimated $505K.
  • Polar Asset Management Partners first reported a position in TG Therapeutics in Q4 2023 and held it in 2 quarters.
  • Polar Asset Management Partners's TG Therapeutics position peaked at $4.59M in Q4 2023.
  • 259 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2024.

Based on Polar Asset Management Partners's 13F filing for Q2 2024, filed 14 Aug 2024.